Cubist Systematic Strategies, LLC Immuno Gen, Inc. Transaction History

Cubist Systematic Strategies, LLC

$15.8 Billion
Q3 2024

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$12.46 - $29.95 $3.91 Million - $9.39 Million	313,550 Added 1170.14%	340,346 $10.1 Million
Q3 2023 Nov 14, 2023	SELL	$14.09 - $19.87 $1.94 Million - $2.74 Million	-137,978 Reduced 83.74%	26,796 $425,000
Q2 2023 Aug 14, 2023	BUY	$3.75 - $20.05 $575,021 - $3.07 Million	153,339 Added 1340.96%	164,774 $3.11 Million
Q1 2023 May 15, 2023	SELL	$3.67 - $4.92 $904,056 - $1.21 Million	-246,337 Reduced 95.56%	11,435 $43,000
Q4 2022 Feb 14, 2023	SELL	$4.55 - $6.31 $468,640 - $649,917	-102,998 Reduced 28.55%	257,772 $1.28 Million
Q3 2022 Nov 14, 2022	BUY	$4.48 - $6.47 $575,133 - $830,605	128,378 Added 55.24%	360,770 $1.72 Million
Q2 2022 Aug 15, 2022	BUY	$3.15 - $5.76 $292,439 - $534,746	92,838 Added 66.52%	232,392 $1.05 Million
Q1 2022 May 16, 2022	SELL	$4.26 - $7.48 $1.35 Million - $2.38 Million	-317,733 Reduced 69.48%	139,554 $664,000
Q4 2021 Feb 14, 2022	BUY	$4.75 - $7.5 $1.78 Million - $2.81 Million	375,249 Added 457.41%	457,287 $3.39 Million
Q3 2021 Nov 15, 2021	SELL	$5.02 - $6.59 $459,535 - $603,255	-91,541 Reduced 52.74%	82,038 $465,000
Q2 2021 Aug 16, 2021	BUY	$5.79 - $8.6 $795,621 - $1.18 Million	137,413 Added 379.95%	173,579 $1.14 Million
Q1 2021 May 17, 2021	SELL	$6.5 - $10.53 $995,143 - $1.61 Million	-153,099 Reduced 80.89%	36,166 $293,000
Q4 2020 Feb 16, 2021	BUY	$3.7 - $7.66 $647,696 - $1.34 Million	175,053 Added 1231.73%	189,265 $1.22 Million
Q3 2020 Nov 16, 2020	SELL	$3.45 - $4.89 $64,866 - $91,941	-18,802 Reduced 56.95%	14,212 $51,000
Q2 2020 Aug 14, 2020	BUY	$3.32 - $5.34 $10,122 - $16,281	3,049 Added 10.18%	33,014 $152,000
Q1 2020 May 15, 2020	BUY	$2.12 - $6.8 $11,272 - $36,155	5,317 Added 21.57%	29,965 $102,000
Q4 2019 Feb 14, 2020	BUY	$2.25 - $5.8 $30,287 - $78,073	13,461 Added 120.33%	24,648 $126,000
Q3 2019 Nov 14, 2019	SELL	$2.22 - $3.39 $92,209 - $140,807	-41,536 Reduced 78.78%	11,187 $27,000
Q2 2019 Aug 14, 2019	SELL	$1.8 - $3.3 $10,486 - $19,225	-5,826 Reduced 9.95%	52,723 $114,000
Q1 2019 May 15, 2019	BUY	$2.41 - $5.91 $45,500 - $111,580	18,880 Added 47.59%	58,549 $159,000
Q4 2018 Feb 14, 2019	BUY	$3.94 - $9.7 $133,369 - $328,345	33,850 Added 581.72%	39,669 $190,000
Q3 2018 Nov 14, 2018	SELL	$8.6 - $11.26 $28,896 - $37,833	-3,360 Reduced 36.61%	5,819 $55,000
Q2 2018 Aug 14, 2018	SELL	$9.52 - $12.15 $23,819 - $30,399	-2,502 Reduced 21.42%	9,179 $89,000
Q1 2018 May 15, 2018	SELL	$6.7 - $12.95 $318,544 - $615,694	-47,544 Reduced 80.28%	11,681 $123,000
Q4 2017 Feb 14, 2018	BUY	$5.07 - $7.92 $205,466 - $320,965	40,526 Added 216.73%	59,225 $380,000
Q3 2017 Nov 14, 2017	BUY	$5.4 - $8.47 $100,974 - $158,380	18,699	18,699 $143,000

Others Institutions Holding IMGN

# of Institutions

Shares Held

1.41M

Call Options Held

Put Options Held

View Full List

About ImmunoGen, Inc.

Ticker IMGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 220,712,992
Description
ImmunoGen, Inc., a clinical-stage biotechnology company, develops antibody-drug conjugate (ADC) therapies to treat cancer. The company's product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha (FRa), which is in Phase III clinical trial for the treatment of platinum-resistant ovarian cancer; and Pivekimab sun...

More about IMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.

Account